NP202

· Armaron Bio Pty Ltd

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for NP202, covering 2017-06-28 to 2017-06-28. Get the full timeline:

Most recent: Clinical Trial Update: NP202 for Treatment of Post -STEMI Left Ventricular Systolic Dysfunction [Phase 2]